Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.
Tenecteplase provides comparable safety and effectiveness outcomes for acute ischemic stroke as alteplase, new research ...
The following is a summary of “Effect of sarcopenia on prognosis in patients with mild acute ischemic stroke: a prospective ...
The risk of a full-blown stroke will remain high for at least a decade after a person has a slight brush with stroke, in the ...
Ali, H. , Ghaysaa, H. , Jaafar, W. and Malek, M. (2025) Ischemic Stroke Following Coronary Angiography: A Case Report. Case ...
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke ... patients who achieved a modified Rankin Scale score of 0-1 at 90 ...
No significant difference seen in terms of effectiveness or safety outcomes, including functional independence at discharge ...
The usage of tenecteplase in patients with acute ischemic stroke was associated with similar effectiveness and safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback